| [1] |
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013 [J]. Lancet, 2014, 384(9945): 766-781.
|
| [2] |
World health organization. Obesity and overweight [EB/OL]. [2018-02-16].
URL
|
| [3] |
Swinburn BA, Sacks G, Hall K D, et al. The global obesity pandemic: shaped by global drivers and local environments [J]. Lancet, 2011, 378(9793): 804-814.
|
| [4] |
Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective [J]. Endocrine Reviews, 2006, 27(7): 750-761.
|
| [5] |
Rosenbaum M, Knight R, Leibel RL. The gut microbiota in human energy homeostasis and obesity [J]. Trends in Endocrinology & Metabolism Tem, 2015, 26(9): 493.
|
| [6] |
Portincasa P, Ciaula AD, Bari OD, et al. Management of gallstones and its related complications [J]. Expert Review of Gastroenterology & Hepatology, 2016, 10(1): 93-112.
|
| [7] |
Wolf K J, Lorenz RG. Gut Microbiota and Obesity [J]. Clinical Nutrition Experimental, 2012, 30(2): 196-200.
|
| [8] |
Cesaro C, Tiso A, Prete AD, et al. Gut microbiota and probiotics in chronic liver diseases [J]. Digest Liver Dis,2011, 43(6): 431-438.
|
| [9] |
Zaneveld J, Turnbaugh PJ, Lozupone C, et al. Host-bacterial coevolution and the search for new drug targets [J]. Current Opinion in Chemical Biology, 2008, 12(1): 109-114.
|
| [10] |
Ly NP, Litonjua A, Gold DR, et al. Gut microbiota, probiotics, and vitamin D: Interrelated exposures influencing allergy, asthma, and obesity? [J]. Journal of Allergy and Clinical Immunology, 2011, 127(5): 1087-1094.
|
| [11] |
Claesson MJ, Cusack S, O'Sullivan O, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly [J]. Proc Natl Acad Sci USA, 2011, 108 Suppl 1(11): 4586-4591.
|
| [12] |
Dibaise JK, Zhang H, Crowell MD, et al. Gut Microbiota and Its Possible Relationship With Obesity [J]. Mayo Clinic Proceedings, 2008, 83(4): 460-469.
|
| [13] |
Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function [J]. British Journal of Nutrition, 1998, 80.
|
| [14] |
Tsai F, Coyle WJ. The microbiome and obesity: Is obesity linked to our gut flora? [J]. Current Gastroenterology Reports, 2009, 11(4): 307-313.
|
| [15] |
Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage [J]. Proc Natl Acad Sci, 2004, 101(44):15718-15723.
|
| [16] |
Bäckhed F, Manchester JK, Semenkovich CF, et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice [J]. Proceedings of the National Academy of Sciences, 2007, 104(3): 979-984.
|
| [17] |
Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: Human gut microbes associated with obesity [J]. Nature, 2006, 444(7122): 1022-1023.
|
| [18] |
Cotillard, A, Kennedy SP, Kong LC , et al. Corrigendum: Dietary intervention impact on gut microbial gene richness [J]. Nature, 2013, 502(7472): 580-580.
|
| [19] |
Park DY, Ahn YT, Park SH, et al. Supplementation of Lactobacillus curvatus KY1032 in Diet-Induced Obese Mice Is Associated with Gut Microbial Changes and Reduction in Obesity [J]. PLoS ONE, 2013, 8(3): e59470.
|
| [20] |
Rowland IR, Capurso L, Collins K, et al. Current level of consensus on probiotic science--report of an expert meeting--London, 23 November 2009 [J]. Gut Microbes, 2010, 1(6): 436.
|
| [21] |
Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: A Mendelian randomization study [J]. Hepatology, 2013, 58(6): 2133-2141.
|
| [22] |
Portincasa P, Moschetta A, Palasciano G. From lipid secretion to cholesterol crystallization in bile. Relevance in cholesterol gallstone disease [J]. Annals of Hepatology, 2002, 1(3): 121-128.
|
| [23] |
Portincasa P, Moschetta A, Palasciano G. From lipid secretion to cholesterol crystallization in bile. Relevance in cholesterol gallstone disease [J]. Annals of Hepatology, 2002, 1(3): 121-128.
|
| [24] |
陈玉生, 顾婷婷. 胆石症患病的饮食行为因素分析 [J]. 健康沿, 2017, 26(12): 116.
|
| [25] |
付俊俐, 王卫星, 郭素菊. 胆囊切除术后肠道菌群及sIgA含量的研究 [J]. 临床外科杂志, 2005, 13(2): 95-97.
|
| [26] |
曲红光, 杨德庆. 胆囊切除患者肠道菌群变化的临床观察 [J]. 中华胃食管反流病电子杂志, 2015, 2(2): 99-101.
|
| [27] |
郭素菊, 付俊俐. 胆囊切除术后肠道菌群及免疫功能的研究 [J]. 中国卫生检验杂志, 2006, 16(2): 229-230.
|
| [28] |
Wenxue W, , Junfeng W, , Julan L , et al. Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction [J]. Frontiers in Microbiology, 2018, 9: 1402.
|
| [29] |
Boyer JL. Bile formation and secretion [J]. Compr Physiol, 2013, 3(3): 1035-1078.
|
| [30] |
Gadaleta RM, van Erpecum KJ, Oldenburg B, et al. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease [J]. Gut, 2011, 60(4): 463-472.
|
| [31] |
Keren N, Konikoff FM, Paitan Y, et al. Interactions between the intestinal microbiota and bile acids in gallstones patients [J]. Environmental Microbiology Reports, 2015, 7(6): 874-880.
|
| [32] |
Lorenzo-Zúñiga V, Bartolí R, Planas R, et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats [J]. Hepatology, 2003, 37(3): 551-557.
|
| [33] |
Gérard Philippe. Metabolism of Cholesterol and Bile Acids by the Gut Microbiota [J]. Pathogens, 2013, 3(1): 14-24.
|
| [34] |
Berr F, Stellaard F, Pratschke E, et al. Effects of cholecystectomy on the kinetics of primary and secondary bile acid [J].J Clin Invest, 1989, 83(5): 1541-1550.
|